These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 38224550)
1. Increased activity of MAPKAPK2 within mesenchymal cells as a target for inflammation associated fibrosis in Crohn's Disease. Chulkina M; Rohmer C; McAninch S; Panganiban RP; Villéger R; Portolese A; Ciocirlan J; Yang W; Cohen C; Koltun W; Valentine JF; Cong Y; Yochum G; Beswick EJ; Pinchuk IV J Crohns Colitis; 2024 Jan; ():. PubMed ID: 38224550 [TBL] [Abstract][Full Text] [Related]
2. Expression of Programmed Death-Ligand 1 by Human Colonic CD90 Beswick EJ; Grim C; Singh A; Aguirre JE; Tafoya M; Qiu S; Rogler G; McKee R; Samedi V; Ma TY; Reyes VE; Powell DW; Pinchuk IV Front Immunol; 2018; 9():1125. PubMed ID: 29910803 [TBL] [Abstract][Full Text] [Related]
3. MK2 Inhibitors as a Potential Crohn's Disease Treatment Approach for Regulating MMP Expression, Cleavage of Checkpoint Molecules and T Cell Activity. Lebish EJ; Morgan NJ; Valentine JF; Beswick EJ Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36558958 [TBL] [Abstract][Full Text] [Related]
4. Treatment of Intestinal Fibrosis in Experimental Inflammatory Bowel Disease by the Pleiotropic Actions of a Local Rho Kinase Inhibitor. Holvoet T; Devriese S; Castermans K; Boland S; Leysen D; Vandewynckel YP; Devisscher L; Van den Bossche L; Van Welden S; Dullaers M; Vandenbroucke RE; De Rycke R; Geboes K; Bourin A; Defert O; Hindryckx P; De Vos M; Laukens D Gastroenterology; 2017 Oct; 153(4):1054-1067. PubMed ID: 28642198 [TBL] [Abstract][Full Text] [Related]
5. TWIST1+FAP+ fibroblasts in the pathogenesis of intestinal fibrosis in Crohn's disease. Zhang Y; Wang J; Sun H; Xun Z; He Z; Zhao Y; Qi J; Sun S; Yang Q; Gu Y; Zhang L; Zhou C; Ye Y; Wu N; Zou D; Su B J Clin Invest; 2024 Jul; ():. PubMed ID: 39024569 [TBL] [Abstract][Full Text] [Related]
6. Increased expression of yes-associated protein/YAP and transcriptional coactivator with PDZ-binding motif/TAZ activates intestinal fibroblasts to promote intestinal obstruction in Crohn's disease. Ou W; Xu W; Liu F; Guo Y; Huang Z; Feng T; Liu CY; Du P EBioMedicine; 2021 Jul; 69():103452. PubMed ID: 34186485 [TBL] [Abstract][Full Text] [Related]
7. Mesenchymal MAPKAPK2/HSP27 drives intestinal carcinogenesis. Henriques A; Koliaraki V; Kollias G Proc Natl Acad Sci U S A; 2018 Jun; 115(24):E5546-E5555. PubMed ID: 29844172 [TBL] [Abstract][Full Text] [Related]
8. IL-10 is not anti-fibrotic but pro-fibrotic in endometriosis: IL-10 treatment of endometriotic stromal cells in vitro promotes myofibroblast proliferation and collagen type I protein expression. Matsuzaki S; Pouly JL; Canis M Hum Reprod; 2023 Jan; 38(1):14-29. PubMed ID: 36413036 [TBL] [Abstract][Full Text] [Related]
10. Hallmarks of epithelial to mesenchymal transition are detectable in Crohn's disease associated intestinal fibrosis. Scharl M; Huber N; Lang S; Fürst A; Jehle E; Rogler G Clin Transl Med; 2015; 4():1. PubMed ID: 25852817 [TBL] [Abstract][Full Text] [Related]
11. Anti-fibrogenic Potential of Mesenchymal Stromal Cells in Treating Fibrosis in Crohn's Disease. Lian L; Huang Q; Zhang L; Qin H; He X; He X; Ke J; Xie M; Lan P Dig Dis Sci; 2018 Jul; 63(7):1821-1834. PubMed ID: 29704139 [TBL] [Abstract][Full Text] [Related]
12. Mitogen-activated Protein Kinase-activated Protein Kinase 2 Inhibition Attenuates Fibroblast Invasion and Severe Lung Fibrosis. Liang J; Liu N; Liu X; Mena JM; Xie T; Geng Y; Huan C; Zhang Y; Taghavifar F; Huang G; Kurkciyan A; Barron V; Jiang D; Noble PW Am J Respir Cell Mol Biol; 2019 Jan; 60(1):41-48. PubMed ID: 30130411 [TBL] [Abstract][Full Text] [Related]
13. Wu-Mei-Wan ameliorates chronic colitis-associated intestinal fibrosis through inhibiting fibroblast activation. Wu F; Shao Q; Hu M; Zhao Y; Dong R; Fang K; Xu L; Zou X; Lu F; Li J; Chen G J Ethnopharmacol; 2020 Apr; 252():112580. PubMed ID: 31972322 [TBL] [Abstract][Full Text] [Related]
14. Creeping fat exhibits distinct Inflammation-specific adipogenic preadipocytes in Crohn's disease. Hwang N; Kang D; Shin SJ; Yoon BK; Chun J; Kim JW; Fang S Front Immunol; 2023; 14():1198905. PubMed ID: 38111581 [TBL] [Abstract][Full Text] [Related]